TD Asset Management Inc

Position in AURA — Aura Biosciences, Inc.

CIK 1056053 Toronto, A6

Position in AURA

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$270,958

+$50,223 QoQ

Shares Held

40,502

0.0% QoQ

Ownership

0.039%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

TD Asset Management Inc holds $1,314,505,240 across 121 Biotechnology names. AURA ranks #114 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	350,923	$271,137,146
2	VRTX	Vertex Pharmaceuticals Inc / Ma	228,195	$101,898,194
3	ALNY	Alnylam Pharmaceuticals, Inc.	281,848	$93,255,047
4	HALO	Halozyme Therapeutics, Inc.	1,168,666	$75,530,883
5	ARGX	Argenx SE	80,824	$59,021,726
6	ASND	Ascendis Pharma A/S	217,992	$49,861,310
7	IONS	Ionis Pharmaceuticals Inc	529,954	$39,794,245
8	RVMD	Revolution Medicines, Inc.	317,811	$30,907,119

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$270,958	40,502	0.0%	Shares	Sole	2026-05-11
2025-12-31	$220,735	40,502	-41.3%	Shares	Sole	2026-02-10
2025-09-30	$426,605	69,030	0.0%	Shares	Sole	2025-11-10
2025-06-30	$432,127	69,030	0.0%	Shares	Sole	2025-07-28
2025-03-31	$404,515	69,030	0.0%	Shares	Sole	2025-05-07
2024-12-31	$567,426	69,030	+15.0%	Shares	Sole	2025-02-11
2024-09-30	$534,867	60,030	-44.4%	Shares	Sole	2024-11-01
2024-06-30	$815,814	107,912	0.0%	Shares	Sole	2024-08-02
2024-03-31	$847,109	107,912	0.0%	Shares	Sole	2024-05-08
2023-12-31	$956,100	107,912	0.0%	Shares	Sole	2024-02-12
2023-09-30	$967,970	107,912	+100.0%	Shares	Sole	2023-10-27
2023-06-30	$666,356	53,956	0.0%	Shares	Sole	2023-08-09
2023-03-31	$500,711	53,956	0.0%	Shares	Sole	2023-05-10
2022-12-31	$566,538	53,956	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.